Testing effectiveness (Phase 2)Study completedNCT01176552
What this trial is testing
Granulocyte-macrophage Colony-stimulating Factor, Interferon and Interleukin-2 as Adjuvant Treatment for Renal Cancer
Who this might be right for
Renal Cell Carcinoma
Kidney Cancer Research Bureau 35